Used in pharmaceutical research as a key intermediate in the synthesis of protease inhibitors, particularly for antiviral drug development. Its structure supports binding to enzyme active sites, making it valuable in designing inhibitors targeting viral replication. The phosphonic acid group enhances bioavailability and metabolic stability, which improves drug efficacy. Commonly explored in treatments for hepatitis C and other viral infections due to its strong target specificity and resistance profile.